Innate immune responses to Pseudomonas aeruginosa infection

Microbes and Infection

Volumn 13, Issue 14-15, 2011, Pages 1133-1145

  Lavoie, Elise G ^a   Wangdi, Tamding ^a   Kazmierczak, Barbara I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Murine models; Pneumonia; Pseudomonas aeruginosa

Indexed keywords

INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PROTEINASE ACTIVATED RECEPTOR; REACTIVE NITROGEN SPECIES; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL CLEARANCE; BACTERIAL SECRETION SYSTEM; CD8+ T LYMPHOCYTE; CELL DEATH; CELL SURFACE; COMPLEMENT SYSTEM; DENDRITIC CELL; DISEASE MODEL; DISEASE PREDISPOSITION; DOWN REGULATION; EPITHELIUM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFECTION; INNATE IMMUNITY; LEUKOCYTE ADHESION DEFICIENCY; LOBAR PNEUMONIA; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LYMPHOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; SHORT SURVEY; SURVIVAL; T LYMPHOCYTE; TYPE II SECRETION SYSTEM; TYPE III SECRETION SYSTEM;

ANIMALS; BACTERIAL PROTEINS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; NEUTROPHILS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

MAMMALIA; MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 81155152426     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.07.011     Document Type: Short Survey

References (115)

1. Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 2011, 24:29-70.
2. Chastre J., Fagon J.-Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2002, 165:867-903.
3. Gaynes R., Edwards J.R., National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 2005, 41:848-854.
4. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. 2006, 103:8487-8492.
5. Murray T.S., Ledizet M., Kazmierczak B.I. Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 2010, 59:511-520.
6. Palmer K.L., Mashburn L.M., Singh P.K., Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 2005, 187:5267-5277.
7. Wolfgang M.C., Jyot J., Goodman A.L., Ramphal R., Lory S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. 2004, 101:6664-6668.
8. Jyot J., Sonawane A., Wu W., Ramphal R. Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol. Microbiol. 2007, 63:1026-1038.
9. Ernst R.K., Hajjar A.M., Tsai J.H., Moskowitz S.M., Wilson C.B., Miller S.I. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J. Endotoxin Res. 2003, 9:395-400.
10. Bleves S., Viarre V., Salacha R., Michel G.P.F., Filloux A., Voulhoux R. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int. J. Med. Microbiol. 2010, 300:534-543.
11. Hauser A.R. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 2009, 7:654-665.
12. Schultz M.J., Rijneveld A.W., Florquin S., Speelman P., van Deventer S.J.H., van der Poll T. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice. J. Med. Microbiol. 2001, 50:822-827.
13. Jyot J., Balloy V., Jouvion G., Verma A., Touqui L., Huerre M., Chignard M., Ramphal R. Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J. Infect. Dis. 2011, 203:1369-1377.
14. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., Greenberg E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764.
15. Shaver C.M., Hauser A.R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS and ExoT to virulence in the lung. Infect. Immun. 2004, 72:6969-6977.
16. Lee V.T., Smith R.S., Tummler B., Lory S. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect. Immun. 2005, 73:1695-1705.
17. Vance R.E., Rietsch A., Mekalanos J.J. Role of the Type III secreted exoenzymes S, T and Y in systemic spread of Pseudomonas aeruginosa PA01 in vivo. Infect. Immun. 2005, 73:1705-1713.
18. El Solh A.A., Akinnusi M.E., Wiener-Kronish J.P., Lynch S.V., Pineda L.A., Szarpa K. Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2008, 178:513-519.
19. Hauser A., Cobb E., Bodi M., Mariscal D., Valles J., Engel J., Rello J. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 2002, 30:521-528.
20. Roy-Burman A., Savel R.H., Racine S., Swanson B.L., Revadigar N.S., Fujimoto J., Sawa T., Frank D.W., Wiener-Kronish J.P. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 2001, 183:1767-1774.
21. Sutterwala F.S., Mijares L.A., Li L., Ogura Y., Kazmierczak B.I., Flavell R.A. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 2007, 204:2235-2245.
22. Finck-Barbancon V., Goranson J., Zhu L., Sawa T., Wiener-Kronish J.P., Fleiszig S.M.J., Wu C., Mende-Mueller L., Frank D. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 1997, 25:547-557.
23. Hauser A.R., Kang P.J., Engel J. PepA, a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Microbiol. 1998, 27:807-818.
24. Barbieri J.T., Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 2004, 152:79-92.
25. Garrity-Ryan L., Kazmierczak B., Kowal R., Comolli J., Hauser A., Engel J. The arginine finger domain of ExoT is required for actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 2000, 68:7100-7113.
26. Rocha C.L., Coburn J., Rucks E.A., Olson J.C. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect. Immun. 2003, 71:5296-5305.
27. Diaz M.H., Hauser A.R. Pseudomonas aeruginosa cytotoxin ExoU is Injected into phagocytic cells during acute pneumonia. Infect. Immun. 2010, 78:1447-1456.
28. Diaz M.H., Shaver C.M., King J.D., Musunuri S., Kazzaz J.A., Hauser A.R. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 2008, 76:4414-4421.
29. Prince L.R., Bianchi S.M., Vaughan K.M., Bewley M.A., Marriott H.M., Walmsley S.R., Taylor G.W., Buttle D.J., Sabroe I., Dockrell D.H., Whyte M.K. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J. Immunol. 2008, 180:3502-3511.
30. Allen L., Dockrell D.H., Pattery T., Lee D.G., Cornelis P., Hellewell P.G., Whyte M.K.B. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J. Immunol. 2005, 174:3643-3649.
31. Lau G.W., Ran H., Kong F., Hassett D.J., Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect. Immun. 2004, 72:4275-4278.
32. Van Gennip M., Christensen L.D., Alhede M., Phipps R., Jensen P.O., Christophersen L., Pamp S.J., Moser C., Mikkelsen P.J., Koh A.Y., Tolker-Nielsen T., Pier G.B., Hoiby N., Givskov M., Bjarnsholt T. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 2009, 117:537-546.
33. Caldwell C.C., Chen Y., Goetzmann H.S., Hao Y., Borchers M.T., Hassett D.J., Young L.R., Mavrodi D., Thomashow L., Lau G.W. Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis. Am. J. Pathol. 2009, 175:2473-2488.
34. Whiteley M., Bangera M.G., Bumgarner R.E., Parsek M.R., Teitzel G.M., Lory S., Greenberg E.P. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001, 413:860-864.
35. R. Le Berre, S. Nguyen, E. Nowak, E. Kipnis, M. Pierre, L. Quenee, F. Ader, S. Lancel, R. Courcol, B.P. Guery, K. Faure, Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia, Crit. Care Med. 39, in press, doi:10.1097/CCM.0b013e31821e899fs.
36. Mijares L.A., Wangdi T., Sokol C., Homer R., Medzhitov R., Kazmierczak B.I. Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J. Immunol. 2011, 186:7080-7088.
37. Skerrett S.J., Liggitt H.D., Hajjar A.M., Wilson C.B. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J. Immunol. 2004, 172:3377-3381.
38. Feuillet V., Medjane S., Mondor I., Demaria O., Pagni P.P., Galan J.E., Flavell R.A., Alexopoulou L. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl. Acad. Sci. 2006, 103:12487-12492.
39. Ramphal R., Balloy V., Jyot J., Verma A., Si-Tahar M., Chignard M. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 2008, 181:586-592.
40. Skerrett S.J., Wilson C.B., Liggitt H.D., Hajjar A.M. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:312-322.
41. Faure K., Sawa T., Ajayi T., Fujimoto J., Moriyama K., Shime N., Wiener-Kronish J.P. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Resp. Res. 2004, 5:1-10.
42. Wangdi T., Mijares L.A., Kazmierczak B.I. In vivo discrimination of T3SS-positive and -negative Pseudomonas aeruginosa via a caspase-1-dependent pathway. Infect. Immun. 2010, 78:4744-4753.
43. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfield J., Towne E., Tracey M.D., Wardwell S., Wei F.-Y., Wong W., Kamen R., Seshadri T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995, 80:401-411.
44. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10:241-247.
45. Franchi L., Stoolman J., Kanneganti T., Verma A., Ramphal R., Nunez G. Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur. J. Immunol. 2007, 37:3030-3039.
46. Miao E.A., Ernst R.K., Dors M., Mao D.P., Aderem A. Pseudomonas aeruginosa activates caspase 1 through IPAF. Proc. Natl. Acad. Sci. 2008, 105:2562-2567.
47. Galle M., Schotte P., Haegman M., Wullaert A., Yang H.J., Jin S., Beyaert R. The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1β maturation. J. Cell. Mol. Med. 2008, 12:1767-1776.
48. Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader M.W., Miller S.I., Aderem A. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 2006, 7:569-575.
49. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. 2010, 107:3076-3080.
50. Arlehamn C.S.L., Petrilli V., Gross O., Tschopp J., Evans T.J. The role of potassium in inflammasome activation by bacteria. J. Biol. Chem. 2010, 285:10508-10518.
51. Hajjar A.M., Harowicz H., Liggitt H.D., Fink P.J., Wilson C.B., Skerrett S.J. An essential role for non-bone-marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am. J. Respir. Cell Mol. Biol. 2005, 33:470-475.
52. Schultz M.J., Rijneveld A.W., Florquin S., Edwards C.K., Dinarello C.A., van der Poll T. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L285-L290.
53. Koh A.Y., Priebe G.R., Ray C., van Rooijen N., Pier G.B. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 2009, 77:5300-5310.
54. Drusano G.L., VanScoy B., Liu W., Fikes S., Brown B.S., Louie A. Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia. Antimicrob. Agents Chemother. 2011, 55:2693-2695.
55. Morris A.C., Kefala K., Wilkinson T.S., Dhaliwal K., Farrell L., Walsh T., Mackenzie S.J., Reid H., Davidson D.J., Haslett C., Rossi A.G., Sallenave J.-M., Simpson A.J. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am. J. Respir. Crit. Care Med. 2009, 180:19-28.
56. Tsai W.C., Strieter R.M., Mehrad B., Newstead M.W., Zeng X., Standiford T.J. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 2000, 68:4289-4296.
57. Qin L., Quinlan W.M., Doyle N.A., Graham L., Sligh J.E., Takei F., Beaudet A.L., Doerschuk C.M. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 1996, 157:5016-5021.
58. Mizgerd J.P., Horwitz B.H., Quillen H.C., Scott M.L., Doerschuk C.M. Effects of CD18 deficiency on the emigration of murine neutrophils during pneumonia. J. Immunol. 1999, 163:995-999.
59. Gyetko M.R., Sud S., Kendall T., Fuller J.A., Newstead M.W., Standiford T.J. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 2000, 165:1513-1519.
60. Hirche T.O., Benabid R., Deslee G., Gangloff S., Achilefu S., Guenounou M., Lebargy F., Hancock R.E., Belaaouaj A. Neutrophil elastase mediates innate host protection against Pseudomonas aeruginosa. J. Immunol. 2008, 181:4945-4954.
61. Dahlen J.R., Foster D.C., Kisiel W. Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9. Biochim. Biophys. Acta 1999, 1451:233-241.
62. Zhang M., Liu N., Park S.M., Wang Y., Byrne S., Murmann A.E., Bahr S., Peter M.E., Olson S.T., Belaaouaj A., Ashton-Rickardt P.G. Serine protease inhibitor 6-deficient mice have increased neutrophil immunity to Pseudomonas aeruginosa. J. Immunol. 2007, 179:4390-4396.
63. Benarafa C., Priebe G.P., Remold-O'Donnell E. The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J. Exp. Med. 2007, 204:1901-1909.
64. Moraes T.J., Martin R., Plumb J.D., Vachon E., Cameron C.M., Danesh A., Kelvin D.J., Ruf W., Downey G.P. Role of PAR2 in murine pulmonary pseudomonal infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L368-L377.
65. Wink D.A., Hines H.B., Cheng R.Y., Switzer C.H., Flores-Santana W., Vitek M.P., Ridnour L.A., Colton C.A. Nitric oxide and redox mechanisms in the immune response. J. Leukoc. Biol. 2011, 89:873-891.
66. Kakishima K., Shiratsuchi A., Taoka A., Nakanishi Y., Fukumori Y. Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages. Biochem. Biophys. Res. Commun. 2007, 355:587-591.
67. Webert K.E., Vanderzwan J., Duggan M., Scott J.A., McCormack D.G., Lewis J.F., Mehta S. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Crit. Care Med. 2000, 28:2397-2405.
68. Satoh S., Oishi K., Iwagaki A., Senba M., Akaike T., Akiyama M., Mukaida N., Atsushima K.M., Nagatake T. Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin. Exp. Immunol. 2001, 126:266-273.
69. Zhang Y., Li X., Carpinteiro A., Goettel J., Soddemann M., Gulbins E. Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections. Nat. Med. 2011, 17:341-346.
70. Raoust E., Balloy V., Garcia-Verdugo I., Touqui L., Ramphal R., Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS ONE 2009, 4:e7259.
71. Hashimoto S., Pittet J.F., Hong K., Folkesson H., Babgby G., Kobzik L., Frevert C., Watanabe K., Tsurufuji S., Wiener-Kronish J. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol. 1996, 270:L819-L828.
72. Kooguchi K., Hashimoto S., Kobayashi A., Kitamura Y., Kudoh I., Wiener-Kronish J., Sawa T. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 1998, 66:3164-3169.
73. Cheung D.O., Halsey K., Speert D.P. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun. 2000, 68:4585-4592.
74. Amano H., Morimoto K., Senba M., Wang H., Ishida Y., Kumatori A., Yoshimine H., Oishi K., Mukaida N., Nagatake T. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J. Immunol. 2004, 172:398-409.
75. Kannan S., Huang H., Seeger D., Audet A., Chen Y., Huang C., Gao H., Li S., Wu M. Alveolar epithelial type II cells activate alveolar macrophages and mitigate P. aeruginosa infection. PLoS ONE 2009, 4:e4891.
76. Manicone A.M., Birkland T.P., Lin M., Betsuyaku T., van Rooijen N., Lohi J., Keski-Oja J., Wang Y., Skerrett S.J., Parks W.C. Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J. Immunol. 2009, 182:3866-3876.
77. Pene F., Zuber B., Courtine E., Rousseau C., Ouaaz F., Toubiana J., Tazi A., Mira J.-P., Chiche J.-D. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J. Immunol. 2008, 181:8513-8520.
78. Nieuwenhuis E.E.S., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., Corazza N., Colgan S.P., Onderdonk A.B., Blumberg R.S. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002, 8:588-593.
79. Kinjo T., Nakamatsu M., Nakasone C., Yamamoto N., Kinjo Y., Miyagi K., Uezu K., Nakamura K., Higa F., Tateyama M., Takeda K., Nakayama T., Taniguchi M., Kaku M., Fujita J., Kawakami K. NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa. Microbes Infect. 2006, 8:2679-2685.
80. Borchers M.T., Harris N.L., Wesselkamper S.C., Zhang S., Chen Y., Young L., Lau G.W. The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa. Infect. Immun. 2006, 74:2578-2586.
81. Wesselkamper S.C., Eppert B.L., Motz G.T., Lau G.W., Hassett D.J., Borchers M.T. NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection. J. Immunol. 2008, 181:5481-5489.
82. Liu J., Feng Y., Yang K., Li Q., Ye L., Han L., Wan H. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice. FEMS Immunol. Med. Microbiol. 2011, 61:179-188.
83. Sadikot R.T., Zeng H., Joo M., Everhart M.B., Sherrill T.P., Li B., Cheng D.-S., Yull F.E., Christman J.W., Blackwell T.S. Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J. Immunol. 2006, 176:4923-4930.
84. Giannoni E., Sawa T., Allen L., Wiener-Kronish J., Hawgood S. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 2006, 34:704-710.
85. Glasser S.W., Senft A.P., Whitsett J.A., Maxfield M.D., Ross G.F., Richardson T.R., Prows D.R., Xu Y., Korfhagen T.R. Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J. Immunol. 2008, 181:621-628.
86. Alcorn J.F., Wright J.R. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J. Biol. Chem. 2004, 279:30871-30879.
87. Malloy J.L., Veldhuizen R.A., Thibodeaux B.A., O'Callaghan R.J., Wright J.R. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L409-L418.
88. Kuang Z., Hao Y., Hwang S., Zhang S., Kim E., Akinbi H.T., Schurr M.J., Irvin R.T., Hassett D.J., Lau G.W. The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sending. Mol. Microbiol. 2011, 79:1220-1235.
89. Younger J.G., Shankar-Sinha S., Mickiewicz M., Brinkman A.S., Valencia G.A., Sarma J.V., Younkin E.M., Standiford T.J., Zetoune F.S., Ward P.A. Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia. Am. J. Respir. Cell Mol. Biol. 2003, 29:432-438.
90. Höpken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996, 383:86-89.
91. Rhein L.M., Perkins M., Gerard N.P., Gerard C. FcγRIII is protective against Pseudomonas aeruginosa pneumonia. Am. J. Respir. Cell Mol. Biol. 2008, 38:401-406.
92. Mueller-Ortiz S.L., Drouin S.M., Wetsel R.A. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect. Immun. 2004, 72:2899-2906.
93. Skerrett S.J., Martin T.R., Chi E.Y., Peschon J.J., Mohler K.M., Wilson C.B. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am. J. Physiol. 1999, 276:L715-L727.
94. Lee J.H., Del Sorbo L., Khine A.A., de Azavedo J., Low D.E., Bell D., Uhlig S., Slutsky A.S., Zhang H. Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo. Am. J. Respir. Cell Mol. Biol. 2003, 168:1462-1470.
95. Gosselin D., DeSantis J., Boule M., Skamene E., Matouk C., Radzioch D. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 1995, 63:3272-3278.
96. Buret A., Dunkley M.L., Pang G., Clancy R.L., Cripps A.W. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha. Infect. Immun. 1994, 62:5335-5343.
97. Kolls J.K., Lei D., Nelson S., Summer W.R., Greenberg S., Beutler B. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 1995, 171:570-575.
98. Chen G.H., Reddy R.C., Newstead M.W., Tateda K., Kyasapura B.L., Standiford T.J. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 2000, 165:6496-6503.
99. Choi S., Park Y.S., Koga T., Treloar A., Kim K.C. TNF-alpha is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 2011, 44:255-260.
100. Daftarian P.M., Kumar A., Kryworuchko M., Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J. Immunol. 1996, 157:12-20.
101. Ueno K., Koga T., Kato K., Golenbock D.T., Gendler S.J., Kai H., Kim K.C. MUC1 mucin is a negative regulator of Toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 2008, 38:263-268.
102. Wölbeling F., Munder A., Kerber-Momot T., Neumann D., Henning C., Hansen G., Tümmler B., Baumann U. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection. Immunobiology 2011, 216:901-908.
103. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., Lukacs N.W., Strieter R.M., Standiford T.J. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 1999, 162:392-399.
104. Muenzer J.T., Davis C.G., Chang K., Schmidt R.E., Dunne W.M., Coopersmith C.M., Hotchkiss R.S. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 2010, 78:1582-1592.
105. Sun L., Guo R.-F., Newstead M.W., Standiford T.J., Macariola D.R., Shanley T.P. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am. J. Respir. Cell Mol. Biol. 2009, 41:76-84.
106. Spight D., Zhao B., Haas M., Wert S., Denenberg A., Shanley T.P. Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:251-265.
107. Chmiel J.F., Konstan M.W., Saadane A., Krenicky J.E., Lester Kirchner H., Berger M. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am. J. Respir. Crit. Care Med. 2002, 165:1176-1181.
108. Sawa T., Corry D., Gropper M., Ohara M., Kurahashi K., Wiener-Kronish J. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 1997, 159:2858-2866.
109. Conway D.H., Dara J., Bagashev A., Sullivan K.E. Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. J. Allergy Clin. Immunol. 2010, 126:172-175.
110. Picard C., von Bernuth H., Ghandil P., Chrabieh M., Levy O., Arkwright P.D., McDonald D., Geha R.S., Takada H., Krause J.C., Creech C.B., Ku C.L., Ehl S., Maródi L., Al-Muhsen S., Al-Hajjar S., Al-Ghonaium A., Day-Good N.K., Holland S.M., Gallin J.I., Chapel H., Speert D.P., Rodriguez-Gallego C., Colino E., Garty B.Z., Roifman C., Hara T., Yoshikawa H., Nonoyama S., Domachowske J., Issekutz A.C., Tang M., Smart J., Zitnik S.E., Hoarau C., Kumararatne D.S., Thrasher A.J., Davies E.G., Bethune C., Sirvent N., de Ricaud D., Camcioglu Y., Vasconcelos J., Guedes M., Vitor A.B., Rodrigo C., Almazán F., Méndez M., Aróstegui J.I., Alsina L., Fortuny C., Reichenbach J., Verbsky J.W., Bossuyt X., Doffinger R., Abel L., Puel A., Casanova J.L. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 2010, 89:403-425.
111. Picard C., Casanova J.L., Abel L. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 2006, 18:383-390.
112. Howard M.W., Strauss R.G., Johnston R.B. Infections in patients with neutropenia. Am. J. Dis. Child. 1977, 131:788-790.
113. Bodey G.P. Fever and neutropenia: the early years. J. Antimicrob. Chemother. 2009, 63(Suppl. 1):i3-13.
114. Pollard A.J., Heale J.P., Tsang A., Massing B., Speert D.P. Nonopsonic phagocytosis of Pseudomonas aeruginosa: insights from an infant with leukocyte adhesion deficiency. Pediatr. Infect. Dis. J. 2001, 20(2001):452-454.
115. Stoltz D.A., Meyerholz D.K., Pezzulo A.A., Ramachandran S., Rogan M.P., Davis G.J., Hanfland R.A., Wohlford-Lenane C., Dohrn C.L., Bartlett J.A., Nelson G.A., Chang E.H., Taft P.J., Ludwig P.S., Estin M., Hornick E.E., Launspach J.L., Samuel M., Rokhlina T., Karp P.H., Ostedgaard L.S., Uc A., Starner T.D., Horswill A.R., Brogden K.A., Prather R.S., Richter S.S., Shilyansky J., McCray P.B., Zabner J., Welsh M.J. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2010, 2. 29ra31.